1. Home
  2. NVCR vs UFPT Comparison

NVCR vs UFPT Comparison

Compare NVCR & UFPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • UFPT
  • Stock Information
  • Founded
  • NVCR 2000
  • UFPT 1963
  • Country
  • NVCR Switzerland
  • UFPT United States
  • Employees
  • NVCR N/A
  • UFPT N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • UFPT Medical/Dental Instruments
  • Sector
  • NVCR Health Care
  • UFPT Health Care
  • Exchange
  • NVCR Nasdaq
  • UFPT Nasdaq
  • Market Cap
  • NVCR 1.9B
  • UFPT 1.6B
  • IPO Year
  • NVCR 2015
  • UFPT 1993
  • Fundamental
  • Price
  • NVCR $17.44
  • UFPT $234.93
  • Analyst Decision
  • NVCR Buy
  • UFPT Buy
  • Analyst Count
  • NVCR 6
  • UFPT 2
  • Target Price
  • NVCR $32.83
  • UFPT $392.00
  • AVG Volume (30 Days)
  • NVCR 861.0K
  • UFPT 122.0K
  • Earning Date
  • NVCR 04-24-2025
  • UFPT 05-06-2025
  • Dividend Yield
  • NVCR N/A
  • UFPT N/A
  • EPS Growth
  • NVCR N/A
  • UFPT 31.41
  • EPS
  • NVCR N/A
  • UFPT 8.15
  • Revenue
  • NVCR $621,711,000.00
  • UFPT $547,560,000.00
  • Revenue This Year
  • NVCR $2.90
  • UFPT $18.91
  • Revenue Next Year
  • NVCR $10.47
  • UFPT $7.77
  • P/E Ratio
  • NVCR N/A
  • UFPT $28.48
  • Revenue Growth
  • NVCR 18.27
  • UFPT 34.43
  • 52 Week Low
  • NVCR $14.17
  • UFPT $178.26
  • 52 Week High
  • NVCR $34.13
  • UFPT $366.41
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 48.61
  • UFPT 56.30
  • Support Level
  • NVCR $16.19
  • UFPT $193.13
  • Resistance Level
  • NVCR $18.52
  • UFPT $225.43
  • Average True Range (ATR)
  • NVCR 0.85
  • UFPT 11.13
  • MACD
  • NVCR 0.06
  • UFPT 1.81
  • Stochastic Oscillator
  • NVCR 54.82
  • UFPT 75.60

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About UFPT UFP Technologies Inc.

UFP Technologies Inc is a designer and custom manufacturer of components, subassemblies, products, and packaging utilizing specialized foams, films, and plastics for the medical market. The company manufactures its products by converting raw materials using laminating, molding, radio frequency and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.

Share on Social Networks: